Takeda Pharmaceutical Co Ltd (TAK)
13.31
-0.08
(-0.60%)
USD |
NYSE |
May 16, 16:00
13.32
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Market Cap: 41.77B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 41.77B |
| May 15, 2024 | 42.02B |
| May 14, 2024 | 42.21B |
| May 13, 2024 | 41.14B |
| May 10, 2024 | 41.58B |
| May 09, 2024 | 41.96B |
| May 08, 2024 | 40.98B |
| May 07, 2024 | 41.67B |
| May 06, 2024 | 41.92B |
| May 03, 2024 | 41.96B |
| May 02, 2024 | 41.64B |
| May 01, 2024 | 41.39B |
| April 30, 2024 | 41.05B |
| April 29, 2024 | 41.33B |
| April 26, 2024 | 40.89B |
| April 25, 2024 | 41.01B |
| April 24, 2024 | 41.52B |
| April 23, 2024 | 41.99B |
| April 22, 2024 | 41.92B |
| April 19, 2024 | 41.55B |
| April 18, 2024 | 41.30B |
| April 17, 2024 | 41.27B |
| April 16, 2024 | 41.52B |
| April 15, 2024 | 41.36B |
| April 12, 2024 | 41.96B |
| Date | Value |
|---|---|
| April 11, 2024 | 42.61B |
| April 10, 2024 | 42.58B |
| April 09, 2024 | 42.83B |
| April 08, 2024 | 42.90B |
| April 05, 2024 | 42.74B |
| April 04, 2024 | 42.30B |
| April 03, 2024 | 42.46B |
| April 02, 2024 | 42.52B |
| April 01, 2024 | 42.90B |
| March 28, 2024 | 43.58B |
| March 27, 2024 | 44.53B |
| March 26, 2024 | 45.15B |
| March 25, 2024 | 44.40B |
| March 22, 2024 | 45.22B |
| March 21, 2024 | 45.06B |
| March 20, 2024 | 45.66B |
| March 19, 2024 | 45.22B |
| March 18, 2024 | 45.69B |
| March 15, 2024 | 45.40B |
| March 14, 2024 | 45.00B |
| March 13, 2024 | 45.25B |
| March 12, 2024 | 45.09B |
| March 11, 2024 | 45.72B |
| March 08, 2024 | 46.35B |
| March 07, 2024 | 46.63B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
38.61B
Minimum
Oct 19 2022
65.67B
Maximum
Nov 19 2019
50.41B
Average
50.49B
Median
Jan 25 2023
Market Cap Benchmarks
| Astellas Pharma Inc | 17.36B |
| Nxera Pharma Co Ltd | 869.77M |
| PeptiDream Inc | 1.782B |
| Healios KK | 89.54M |
| AnGes Inc | 72.99M |
Market Cap Related Metrics
| PE Ratio | 41.38 |
| PS Ratio | 1.425 |
| Price to Book Value | 0.8692 |
| Price to Free Cash Flow | 25.78 |
| Price | 13.31 |
| Earnings Yield | 2.42% |
| Operating PE Ratio | 33.17 |
| Normalized PE Ratio | 41.38 |